Thursday, July 29


Education, electric shock therapy, FDA, Massachusetts, News UK, UK Weekend

Massachusetts school wins court battle to use electric shock therapy on self-harming disabled students

A Massachusetts school has won an appeal to use electric shock therapy on mentally disabled pupils. A federal court ruled that an earlier FDA ban on the therapy had been outside the agency's area of ​​authority. The United Nations previously said the center's use of electric shock therapy amounted to "torture". See more stories on Insider's business page. A school for developmentally disabled students in Massachusetts has won a controversial appeal to use electric shock therapy on self-harming pupils.In March of last year the Food and Drug Administration (FDA) banned the use of electric shock devices as treatment for individuals en...
Aduhelm, Alzheimer's Disease, biogen, Dispensed, FDA, Healthcare

The head of the FDA is calling for an investigation into her agency’s controversial decision to approve a new Alzheimer’s drug

Interim FDA Commissioner Janet Woodcock has asked for an outside investigation into an Alzheimer's drug approval. The agency approved the drug, Aduhelm, last month, despite a lack of evidence showing the drug slowed the disease. Officials from Biogen and the FDA worked closely together to revive the drug, raising concerns. LoadingSomething is loading. ...
Alzheimer's, alzheimer's drugs, BI Commentary, FDA, Healthcare, Mental Health, Opinión, permalancer, Politics, Public Health, Science, SSRI

The FDA is broken. It’s controversial approval of an ineffective new Alzheimer’s drug proves the agency puts profit over public health.

The agency's approval of a new Alzheimer's drug rightly caused an uproar. But the problems extend far beyond the drug, and far beyond the FDA: Drug science has been corrupted by the pharmaceutical industry. We must get money out of science to have safe and effective drugs. PE Moskowitz is an author and runs Mental Hellth, a newsletter about capitalism and psychology. This is an opinion article. The thoughts expressed are those of the author. LoadingSomething is loading. ...
Apple, Apple Watch, estres postraumatico, FDA, Noticias, perturbaciones en el sueño, pesadilla, pesadillas, TEPT

Apple Watch will control nightmares from post-traumatic stress | Digital Trends Spanish

Many patients with post-traumatic stress disorder (PTSD) experience constant nightmares, which can significantly disturb sleep patterns. This has also been linked to high suicide rates. For this reason, the United States Food and Drug Administration (FDA) approved an application called NightWare, which is designed to help improve sleep for PTSD patients who suffer from constant nightmares. This app will work with Apple Watch and will be available only with a prescription. How does it work? NightWare. Initially, the application spends up to ten nights "learning" the user's sleep patterns. With this information, you are able to create a unique sleep profile. Then it tracks the heart rate and body movement data to detect when the person is having a nightmare. On those occasions, the...
Covid 19, FDA, Noticias, Remdesivir, Salud

Remdesivir: US approves first treatment against COVID-19 | Digital Trends Spanish

The United States Food and Drug Administration (FDA) has approved remdesivir as the first treatment for COVID-19, the disease caused by the SARS-CoV-2 virus. According to the FDA, Veklury, the drug's brand name, was able to reduce recovery time by an average of five days during clinical trials. "Veklury is the first treatment for COVID-19 to receive FDA approval," the government agency said in a release. The drug was approved for use in adult patients and children from the age of 12, who weigh at least 40 kilos and who have required hospitalization for the disease. "Veklury should only be administered in a hospital or healthcare setting capable of providing acute care comparable to inpatient hospital care," the agency stated. Getty Images / Digital Trends Graphic In early October 2...